Differentiated Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Differentiated Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial update evaluating efficacy of Radium 223 in radioactive iodine-refractory bone metastases from differentiated thyroid…
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032) [Phase 2, Phase 3]
Clinical trial update for Anlotinib in differentiated thyroid cancer across Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer [Phase 3]
Phase 3 trial comparing selumetinib to placebo in differentiated thyroid cancer was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer [Phase 2]
A completed Phase 2 trial evaluating donafenib in iodine-131 refractory differentiated thyroid cancer.
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer [Phase 2]
Phase 2 trial update for CUDC-907 in metastatic and locally advanced thyroid cancer; study terminated with results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial update evaluating safety and efficacy of VB-111 in advanced differentiated thyroid cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Sutent Adjunctive Treatment of Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial evaluating Sutent as adjunctive therapy for differentiated thyroid cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: PET-guided External Beam Radiotherapy in Differentiated Thyroid Cancer
A completed clinical trial evaluating PET-guided external beam radiotherapy for differentiated thyroid cancer has been reported.
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer [Phase 3]
A Phase 3 clinical trial evaluated Vandetanib for efficacy and safety in patients with Differentiated thyroid cancer and has completed with …
-
CLINICAL_TRIALS research · 2017-01-20Clinical Trial Update: Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer [Phase 2, Phase 3]
Clinical trial update exploring minimizing radioactive iodine ablation after thyroid remnant in differentiated thyroid cancer (Phase 2/Phase…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) [Phase 3]
Phase 3 clinical trial of lenvatinib in iodine-refractory differentiated thyroid cancer completed with posted results in 2016.
-
CLINICAL_TRIALS research · 2016-09-13Clinical Trial Update: Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
This clinical trial update reports on research assessing quality of life after adjunct radioiodine therapy in patients with differentiated t…
-
CLINICAL_TRIALS approval · 2016-03-16Clinical Trial Update: An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Eisai's lenvatinib expanded access program for radioiodine-refractory differentiated thyroid cancer has resulted in marketing approval for t…
-
CLINICAL_TRIALS research · 2015-12-22Clinical Trial Update: Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
The update describes approaches used in initial management of differentiated thyroid cancer in real-world Chinese settings from a Huazhong U…
-
FDA approval · 2015-07-31FDA Approved: HICON — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
FDA approved a supplemental application for HICON (Sodium Iodide I-131) from Jubilant Radiopharma, resulting in updated labeling for this ra…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen. [Phase 3]
Phase 3 follow-up trial in differentiated thyroid cancer patients who previously participated in a study comparing standard thyroid remnant …
-
CLINICAL_TRIALS research · 2014-06-17Clinical Trial Update: PET Evaluation of Recurrent Differentiated Thyroid Cancer
This clinical trial update covers PET imaging evaluation for recurrent differentiated thyroid cancer in a study sponsored by The Netherlands…
-
EMA label_change · 2014-04-25European Medicines Agency recommends extending use of Nexavar to include treatment of differentiated thyroid cancer
EMA recommends extending the use of Nexavar (sorafenib) to treat differentiated thyroid cancer.
-
CLINICAL_TRIALS research · 2014-03-14Clinical Trial Update: Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer [NA]
This document provides a status update on a completed clinical trial evaluating endogenous TSH stimulation in the follow-up of differentiate…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial of celecoxib for progressive metastatic differentiated thyroid cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer [Phase 3]
Phase 3 trial comparing Nexavar (sorafenib) to placebo in locally advanced/metastatic RAI-refractory differentiated thyroid cancer completed…
-
FDA approval · 2012-12-14FDA Approved: THYROGEN — Supplemental Application (Genzyme Corporation)
FDA approved a supplemental application for THYROGEN (thyrotropin alfa) submitted by Genzyme Corporation. The action updates the product lab…
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Impact of BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated With Tyrosine Kinase Inhibitors
Clinical trial update examining how BRAFV600E intratumor heterogeneity affects treatment of differentiated thyroid cancer with tyrosine kina…
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer [NA]
Study evaluating whether metformin reduces the levothyroxine dose required to suppress TSH in differentiated thyroid cancer; the trial has c…